MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 641 to 660 of 5,858 approvalsPage 33 of 293

TOLCORD 2 FILM COATED TABLET 2 MG

Approval Number: SIN16597P
Approval: Sep 7, 2022

TOLCORD 1 FILM COATED TABLET 1 MG

Approval Number: SIN16598P
Approval: Sep 7, 2022

ARIPRIP 15 TABLET 15MG

Approval Number: SIN16595P
Approval: Sep 6, 2022

ARIPRIP 5 TABLET 5MG

Approval Number: SIN16593P
Approval: Sep 6, 2022

ARIPRIP 10 TABLET 10MG

Approval Number: SIN16594P
Approval: Sep 6, 2022

PANTOBEX DELAYED RELEASE TABLET 20MG

Approval Number: SIN16591P
Approval: Sep 1, 2022

TELFOCUS 80 TABLETS 80MG

Approval Number: SIN16587P
Approval: Sep 1, 2022

TELFOCUS 40 TABLETS 40MG

Approval Number: SIN16588P
Approval: Sep 1, 2022

PANTOBEX DELAYED RELEASE TABLET 40MG

Approval Number: SIN16590P
Approval: Sep 1, 2022

AXCEL CEPHALEXIN-500 CAPSULE 500MG

Approval Number: SIN16585P
Approval: Aug 30, 2022

UPHALEXIN CAPSULE 250 MG

Approval Number: SIN16584P
Approval: Aug 29, 2022

ALSUNI CAPSULES 12.5MG

Approval Number: SIN16579P
Approval: Aug 24, 2022

ALSUNI CAPSULES 50MG

Approval Number: SIN16578P
Approval: Aug 24, 2022

TADILAS FILM-COATED TABLETS 20MG

Approval Number: SIN16580P
Approval: Aug 24, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.